Clinical Neurological Society of America
@NeuroAmerica
Followers
432
Following
201
Statuses
1K
CNSA is an organization of clinical & academic neurologists dedicated to neurology & the neurosciences.
Washington, DC
Joined January 2020
Visit CNSA's library of webinars for information on topics ranging from migraine to telemedicine to biologics and biosimilars. View webinars ▶️
0
0
0
ICYMI: CNSA’s Clinical Proceedings white paper on the utility of biomarker testing for synucleinopathies is now available. Read it here ▶️
0
0
0
DYK? Lifestyle changes are now widely recommended for reducing the risk of Alzheimer's disease. Learn more about prevention and treatment of #Alzheimers in CNSA's Clinical Proceedings white paper. Read paper ▶ Watch the webinar ▶
0
0
0
RT @PracticalNeuro: A new @NeuroAmerica White Paper recommends #biomarker testing to address delays in the diagnosis of #synucleinopathies…
0
1
0
ICYMI: David Houghton, MD, MPH, and Cherry Yu, MD, discussed the utility of biomarker testing for synucleinopathies and reviewed the highlights in CNSA's white paper. Watch the webinar here ▶ Read the white paper ▶
0
0
0
🚨 Register Now 🚨 Join CNSA for a free webinar on Minimizing the Devastating Impact of Synucleinopathies: The Utility of Biomarker Testing on January 29 at 12 pm ET with experts David Houghton, MD, MPH & Cherry Yu, MD. Register today ▶
0
0
0
💻 This Wednesday 💻 Join CNSA for a free webinar on Minimizing the Devastating Impact of Synucleinopathies: The Utility of Biomarker Testing on January 29 at 12 pm ET with experts David Houghton, MD, MPH & Cherry Yu, MD. Register today ▶
0
0
1
📣Calling all neurology providers📣 Join CNSA for a free webinar on Minimizing the Devastating Impact of Synucleinopathies: The Utility of Biomarker Testing on January 29 at 12 pm ET with experts David Houghton, MD, MPH & Cherry Yu, MD. Register today ▶
0
1
1
Today, CNSA launched the first of six episodes of its series “Alzheimer’s Disease: From Pre-diagnosis to Treatment to What’s Next” presented by Marissa Natelson Love, MD. Watch the episode here ▶ Read the white paper ▶
0
0
0
CNSA's Clinical Proceedings white paper on Minimizing the Devestating Impact of Synucleinopathies: The Utility of Biomarker Testing is out now. Read it here ▶
0
0
0
Informative lectures on Neuro-oncology, headache and harnessing AI in neurology by @ADesjardinsMD, @LCharlestonIVMD and Kyle Ruffing, MD, FAAN, for the last day of #CN2025!
0
1
3
An engaging joint session panel discussion on the practice of neurology with the Association of Movement Disorder Advanced Practice Providers at #CN2025. Panel: 🧠 Susan Hickenbottom, MD 🧠 @david_houghton, MD 🧠 Kyle Ruffing, MD, FAAN 🧠 Erin Zinn, MSN, APRN, CNP, ANP-BC
0
0
1
Susan Hickenbottom, MD, presents on palliative care and compassion in a joint session with the @Neuropalcare at #CN2025!
0
0
1
Poster session followed by the Taste and Olfaction: Science and a Sensory Experience Dinner event to close out day 3 of #CN2025!
0
0
1
An insightful conversation with David Houghton, MD, MPH, for the final Meet the Professor session of #CN2025!
0
1
1
Happening Now: Panel discussion on "30 Ideas in 30 Minutes" featuring key insights from the following experts➡️ 📌@Amybrownmd 📌 @david_houghton, MD, MPH 📌 Howard Kirshner, MD 📌 @apeltier_md, MS 📌 Sub Subramony, MD
0
0
2
0
2
0
Deborah Rose, MD, speaks on social and structural determinants of cognitive aging at #CN2025 in a joint session with the @SocBlackNeuro!
0
1
5
.@sumadshah, MD, @david_houghton, MD, & Andy Liu, MD, MS, are discussing the following topics on day 3 of #CN2025! 🧠Updates in neuroimmunology 🧠Continuous dopaminergic stimulation for Parkinson's 🧠Monoclonal antibodies in the treatment of Alzheimer's
0
0
3